Paul R Edick Insider Trading $NLNK LUMOS PHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul R Edick.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul R Edick. Paul R Edick is Director in PDL BIOPHARMA, INC. ($PDLI) and Director in NEWLINK GENETICS CORP ($NLNK) and See Remarks in XERIS PHARMACEUTICALS INC ($XERS) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in Milestone Pharmaceuticals Inc. ($MIST) and Director in Neos Therapeutics, Inc. ($NEOS) and Director in Iterum Therapeutics plc ($ITRM).
Paul R Edick in LUMOS PHARMA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul R Edick: Director
Holdings: 7,906 shares
Current Value: $108,075
Latest Transaction: May 16 2017
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul R Edick in LUMOS PHARMA, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ITRM, NLNK, MIST, NEOS, PDLI, SCMP, XERS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16 2017 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 17.42 | 13,309 | 231,843 | 13,309 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 10.78 | 4,783 | 51,561 | 4,783 | |
| Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 10.78 | 17,773 | 191,593 | 17,773 | |
| May 04 2015 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 44.60 | 3,643 | 162,478 | 3,643 | |
| May 04 2015 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Grant | A | 0.00 | 1,962 | 0 | 7,906 | 5.9 K to 7.9 K (+33.01 %) |
| May 05 2014 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 21.23 | 8,331 | 176,867 | 8,331 | |
| May 05 2014 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Grant | A | 0.00 | 2,944 | 0 | 5,944 | 3 K to 5.9 K (+98.13 %) |
| Jan 06 2014 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| May 10 2013 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 14.71 | 12,000 | 176,520 | 12,000 | |
| Jan 23 2012 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 6.87 | 2,381 | 16,357 | 2,381 | |
| Nov 14 2011 | NLNK | NEWLINK GENETICS C ... | Edick Paul R | Director | Option Exercise | A | 7.00 | 11,904 | 83,328 | 11,904 |
Page: 1